Anushree Chaitanya Shirali, MD

Dr. Shirali is an Associate Professor of Medicine in the Section of Nephrology. She received her medical education at New York Medical College and completed residency training in Internal Medicine at the Albert Einstein College of Medicine/Montefiore Hospital. She obtained Nephrology fellowship training at Yale University and subsequently joined the faculty. As head of the Onco-Nephrology specialty clinic at Yale, she sees patients with cancer with kidney dysfunction, hypertension, or electrolyte abnormalities, including those on early phase clinical trials with emerging therapies. Having published on a variety of topics relevant to the treatment of kidney disease in patients with cancer, she has a particular clinical and research interest in immune checkpoint inhibitors and their kidney related adverse effects. In addition to her clinical activities, she has served on the American Society of Nephrology’s OncoNephrology advisory group, has contributed to the American Society of Nephrology's OncoNephrology curriculum, and is on the editorial board of the Journal of Onco-Nephrology.